Biochemical markers for lung and other diseases

摘要

A bioassay method for quantification of peptide fragments elevated in pulmonary diseases such as COPD, SCC, or IPF, comprising a neoepitope formed at the cleavage site by cleaving elastin with a proteinase in vivo, comprising: Is contacted with an antibody having a specific binding affinity for the neoepitope amino acid sequence and a step of determining the level of binding, wherein the antibody comprises a terminal sequence ......... FGPGVV ......... VPGLGV IKAPKL ... A method that binds to one of the following and antibodies and immunoassay kits used in such a method.